Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cancer
MedTech
FDA approves Caris multi-cancer companion diagnostic test
The company describes the test as the first of its kind to offer simultaneous whole exome sequencing and whole transcriptome sequencing.
Conor Hale
Nov 13, 2024 9:00am
Roche sparks $1.8B-plus discovery deal with Flare Therapeutics
Nov 12, 2024 7:00am
23andMe shutters cancer drug research, lays off 40% of staff
Nov 11, 2024 9:07pm
NYU Langone taps Philips to take its pathology digital
Oct 16, 2024 9:00am
Proscia launches pathology toolkits for building AI models
Oct 3, 2024 1:45pm
AstraZeneca extends AI immuno-oncology R&D pact with Immunai
Sep 26, 2024 9:00am